Former Gen-Probe CEO Carl Hull Leaving Hologic | GenomeWeb

NEW YORK (GenomeWeb News) – Carl Hull is leaving Hologic earlier than planned, the company announced after the close of the market on Tuesday.

In a document filed with the US Securities and Exchange Commission, Hologic said that his retirement from the firm becomes effective Feb. 15.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.